Bronchopulmonary dysplasia and inflammatory biomarkers in the premature neonate

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 93, Issue 6, 2008, Pages

  Bose, Carl L ^a,c   Dammann, C E L ^b   Laughon, M M ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; PROTEINASE; REACTIVE OXYGEN METABOLITE;

ARTIFICIAL VENTILATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM; HUMAN; INFLAMMATORY CELL; LUNG DEVELOPMENT; LUNG DYSPLASIA; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; REVIEW;

BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; CHEMOKINES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFLAMMATION MEDIATORS; PNEUMONIA; REACTIVE OXYGEN SPECIES;

EID: 55349100220     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2007.121327     Document Type: Review

References (73)

1. Horbar JD, Badger GJ, Carpenter JH, et al. Trends in mortality and morbidity for very low birth weight infants, 1991-1999. Pediatrics 2002;110:143-51.
2. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999;46:641-3.
3. Dargaville PA, South M, McDougall PN. Comparison of two methods of diagnostic lung lavage in ventilated infants with lung disease. Am J Respir Crit Care Med 1999;160:771-7.
4. Dargaville PA, South M, Vervaart P, et al. Validity of markers of dilution in small volume lung lavage. Am J Respir Crit Care Med 1999;160:778-84.
5. Truog WE, Ballard PL, Norberg M, et al. Inflammatory markers and mediators in tracheal fluid of premature infants treated with inhaled nitric oxide. Pediatrics 2007;119:670-8.
6. Ozdemir A, Brown MA, Morgan WJ. Markers and mediators of inflammation in neonatal lung disease. Pediatr Pulmonol 1997;23:292-306.
7. Kotecha S. Cytokines in chronic lung disease of prematurity. Eur J Pediatr 1996;155(Suppl 2):S14-17.
8. Speer CP. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med 2006;11:354-62.
9. Ryan RM, Ahmed Q, Lakshminrusimha S. Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia. Clin Rev Allergy Immunol 2008;34:174-90.
10. Whicher JT, Evans SW. Cytokines in disease. Clin Chem 1990;36:1269-81.
11. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006;354:610-21.
12. De Dooy J, Ieven M, Stevens W, et al. High levels of CXCL8 in tracheal aspirate samples taken at birth are associated with adverse respiratory outcome only in preterm infants younger than 28 weeks gestation. Pediatr Pulmonol 2007;42:193-203.
13. D'Angio CT, Basavegowda K, Avissar NE, et al. Comparison of tracheal aspirate and bronchoalveolar lavage specimens from premature infants. Biol Neonate 2002;82:145-9.
14. Baier RJ, Loggins J, Kruger TE. Increased interleukin-8 and monocyte chemoattractant protein-1 concentrations in mechanically ventilated preterm infants with pulmonary hemorrhage. Pediatr Pulmonol 2002;34:131-7.
15. Groneck P, Schmale J, Soditt V, et al. Bronchoalveolar inflammation following airway infection in preterm infants with chronic lung disease. Pediatr Pulmonol 2001;31:331-8.
16. Baier RJ, Loggins J, Kruger TE. Monocyte chemoattractant protein-1 and interleukin-8 are increased in bronchopulmonary dysplasia: relation to isolation of Ureaplasma urealyticum. J Invest Med 2001;49:362-9.
17. Takasaki J, Ogawa Y. Interleukin 8 and granulocyte elastase alpha 1 proteinase inhibitor complex in the tracheobronchial aspirate of infants with chronic lung disease following inter-uterine infection. Acta Paediatr Jpn 1996;38:132-6.
18. Groneck P, Goetze-Speer B, Speer CP. Inflammatory bronchopulmonary response of preterm infants with microbial colonisation of the airways at birth. Arch Dis Child Fetal Neonatal Ed 1996;74:F51-5.
19. Munshi UK, Niu JO, Siddiq MM, et al. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia. Pediatr Pulmonol 1997;24:331-6.
20. Lista G, Castoldi F, Fontana P, et al. Lung inflammation in preterm infants with respiratory distress syndrome: effects of ventilation with different tidal volumes. Pediatr Pulmonol 2006;41:357-63.
21. Kotecha S, Chan B, Azam N, et al. Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1995;72:F90-6.
22. Baier RJ, Majid A, Parupia H, et al. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia. Pediatr Pulmonol 2004;37:137-48.
23. Groneck P, Gotze-Speer B, Oppermann M, et al. Association of pulmonary inflammation and increased microvascular permeability during the development of bronchopulmonary dysplasia: a sequential analysis of inflammatory mediators in respiratory fluids of high-risk preterm neonates. Pediatrics 1994;93:712-18.
24. Liles WC, Van Voorhis WC. Review: nomenclature and biologic significance of cytokines involved in inflammation and the host immune response. J Infect Dis 1995;172:1573-80.
25. Kotecha S, Silverman M, Shaw RJ, et al. Soluble L-selectin concentration in bronchoalveolar lavage fluid obtained from infants who develop chronic lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 1998;78:F143-7.
26. Shimotake TK, Izhar FM, Rumilla K, et al. Interleukin (IL)-1 beta in tracheal aspirates from premature infants induces airway epithelial cell IL-8 expression via an NF-kappa B dependent pathway. Pediatr Res 2004;56:907-13.
27. Jonsson B, Tullus K, Brauner A, et al. Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 1997;77:F198-201.
28. Patterson AM, Taciak V, Lovchik J, et al. Ureaplasma urealyticum respiratory tract colonization is associated with an increase in interleukin 1-beta and tumor necrosis factor alpha relative to interleukin 6 in tracheal aspirates of preterm infants. Pediatr Infect Dis J 1998;17:321-8.
29. Cayabyab RG, Jones CA, Kwong KY, et al. Interleukin-1beta in the bronchoalveolar lavage fluid of premature neonates: a marker for maternal chorioamnionitis and predictor of adverse neonatal outcome. J Matern Fetal Neonatal Med 2003;14:205-11.
30. Kotecha S, Wilson L, Wangoo A, et al. Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 1996;40:250-6.
31. Mahieu LM, De Dooy JJ, Ieven MM, et al. Increased levels of tumor necrosis factor-alpha and decreased levels of interleukin-12 p 70 in tracheal aspirates, within 2 hrs after birth, are associated with mortality among ventilated preterm infants. Pediatr Crit Care Med 2005;6:682-9.
32. Greenlee KJ, Werb Z, Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev 2007;87:69-98.
33. Sweet DG, Curley AE, Chesshyre E, et al. The role of matrix metalloproteinases -9 and -2 in development of neonatal chronic lung disease. Acta Paediatr 2004;93:791-6.
34. Ekekezie II, Thibeault DW, Simon SD, et al. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/ tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics 2004;113:1709-14.
35. Cederqvist K, Sorsa T, Tervahartiala T, et al. Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress. Pediatrics 2001;108:686-92.
36. Altiok O, Yasumatsu R, Bingol-Karakoc G, et al. Imbalance between cysteine proteases and inhibitors in a baboon model of bronchopulmonary dysplasia. Am J Respir Crit Care Med 2006;173:318-26.
37. Bruce MC, Schuyler M, Martin RJ, et al. Risk factors for the degradation of lung elastic fibers in the ventilated neonate. Implications for impaired lung development in bronchopulmonary dysplasia. Am Rev Respir Dis 1992;146:204-12.
38. Thibeault DW, Mabry SM, Ekekezie II, et al. Lung elastic tissue maturation and perturbations during the evolution of chronic lung disease. Pediatrics 2000;106:1452-9.
39. Cederqvist K, Haglund C, Heikkila P, et al. Pulmonary trypsin-2 in the development of bronchopulmonary dysplasia in preterm infants. Pediatrics 2003;112:570-7.
40. Saugstad OD. Oxidative stress in the newborn: a 30-year perspective. Biol Neonate 2005;88:228-36.
41. Contreras M, Hariharan N, Lewandoski JR, et al. Bronchoalveolar oxyradical inflammatory elements herald bronchopulmonary dysplasia. Crit Care Med 1996;24:29-37.
42. Frank L, Sosenko IR. Development of lung antioxidant enzyme system in late gestation: possible implications for the prematurely born infant. J Pediatr 1987;110:9-14.
43. Autor AP, Frank L, Roberts RJ. Developmental characteristics of pulmonary superoxide dismutase: relationship to idiopathic respiratory distress syndrome. Pediatr Res 1976;10:154-8.
44. Sunday ME, Yoder BA, Cuttitta F, et al. Bombesin-like peptide mediates lung injury in a baboon model of bronchopulmonary dysplasia. J Clin Invest 1998;102:584-94.
45. Cullen A, Van Marter LJ, Allred EN, et al. Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia. Am J Respir Crit Care Med 2002;165:1093-7.
46. Subramaniam M, Sugiyama K, Coy DH, et al. Bombesin-like peptides and mast cell responses: relevance to bronchopulmonary dysplasia? Am J Respir Crit Care Med 2003;168:601-11.
47. Spits H, de Waal Malefyt R. Functional characterization of human IL-10. Int Arch Allergy Immunol 1992;99:8-15.
48. Jones CA, Cayabyab RG, Kwong KY, et al. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996;39:966-75.
49. Blahnik MJ, Ramanathan R, Riley CR, Minoo P. Lipopolysaccharide- induced tumor necrosis factor-alpha and IL-10 production by lung macrophages from preterm and term neonates. Pediatr Res 2001;50:726-31.
50. Beresford MW, Shaw NJ. Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome. Pediatr Res 2002;52:973-8.
51. McColm JR, Stenson BJ, Biermasz N, et al. Measurement of interleukin 10 in bronchoalveolar lavage from preterm ventilated infants. Arch Dis Child Fetal Neonatal Ed 2000;82:F156-9.
52. Bernard A, Roels H, Lauwerys R, et al. Human urinary protein 1: evidence for identity with the Clara cell protein and occurrence in respiratory tract and urogenital secretions. Clin Chim Acta 1992;207:239-49.
53. Ramsay PL, DeMayo FJ, Hegemier SE, et al. Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;164:155-61.
54. Gross I, Wilson CM, Ingleson LD, et al. The influence of hormones on the biochemical development of fetal rat lung in organ culture. I. Estrogen. Biochim Biophys Acta 1979;575:375-83.
55. Sime PJ, Xing Z, Graham FL, et al. Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. J Clin Invest 1997;100:768-76.
56. Lecart C, Cayabyab R, Buckley S, et al. Bioactive transforming growth factor-beta in the lungs of extremely low birthweight neonates predicts the need for home oxygen supplementation. Biol Neonate 2000;77:217-23.
57. Hardie WD, Bruno MD, Huelsman KM, et al. Postnatal lung function and morphology in transgenic mice expressing transforming growth factor-alpha. Am J Pathol 1997;151:1075-83.
58. Dammann CE, Nielsen HC, Carraway KL 3rd. Role of neuregulin-1 beta in the developing lung. Am J Respir Crit Care Med 2003;167:1711- 16.
59. Nielsen HC. Epidermal growth factor influences the developmental clock regulating maturation of the fetal lung fibroblast. Biochim Biophys Acta 1989;1012:201-6.
60. Stiles AD, D'Ercole AJ. The insulin-like growth factors and the lung. Am J Respir Cell Mol Biol 1990;3:93-100.
61. Gonzalez AM, Hill DJ, Logan A, et al. Distribution of fibroblast growth factor (FGF)-2 and FGF receptor-1 messenger RNA expression and protein presence in the mid-trimester human fetus. Pediatr Res 1996;39:375-85.
62. Barazzone C, Donati YR, Rochat AF, et al. Keratinocyte growth factor protects alveolar epithelium and endothelium from oxygen-induced injury in mice. Am J Pathol 1999;154:1479-87.
63. Thebaud B. Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity. Neonatology 2007;91:291-7.
64. Lassus P, Ristimaki A, Ylikorkala O, et al. Vascular endothelial growth factor in human preterm lung. Am J Respir Crit Care Med 1999;159:1429-33.
65. Henderson-Smart DJ, Hutchinson JL, Donoghue DA, et al. Prenatal predictors of chronic lung disease in very preterm infants. Arch Dis Child Fetal Neonatal Ed 2006;91:F40-5.
66. Ober C, Hoffjan S. Asthma genetics 2006: the long and winding road to gene discovery. Genes Immun 2006;7:95-100.
67. Strassberg SS, Cristea IA, Qian D, et al. Single nucleotide polymorphisms of tumor necrosis factor-alpha and the susceptibility to bronchopulmonary dysplasia. Pediatr Pulmonol 2007;42:29-36.
68. Lin HC, Tsai FJ, Tsai CH, et al. Cytokine polymorphisms and chronic lung disease in small preterm infants. Arch Dis Child Fetal Neonatal Ed 2005;90:F93-4.
69. Hedberg CL, Adcock K, Martin J, et al. Tumor necrosis factor alpha -308 polymorphism associated with increased sepsis mortality in ventilated very low birth weight infants. Pediatr Infect Dis J 2004;23:424-8.
70. Adcock K, Hedberg C, Loggins J, et al. The TNF-alpha -308, MCP-1 -2518 and TGF-beta1 +915 polymorphisms are not associated with the development of chronic lung disease in very low birth weight infants. Genes Immun 2003;4:420-6.
71. Kazzi SN, Kim UO, Quasney MW, et al. Polymorphism of tumor necrosis factor-alpha and risk and severity of bronchopulmonary dysplasia among very low birth weight infants. Pediatrics 2004;114:e243-8.
72. Brenneman DE, Schultzberg M, Bartfai T, et al. Cytokine regulation of neuronal survival. J Neurochem 1992;58:454-60.
73. Barsig J, Kusters S, Vogt K, et al. Lipopolysaccharide- induced interleukin-10 in mice: role of endogenous tumor necrosis factor-alpha. Eur J Immunol 1995;25:2888-93.